(Q37254563)

19 August 2017

1 reference

title

Rational use of diuretics in acute decompensated heart failure (English)

1 reference

Acute decompensated heart failure

19 August 2017

0 references

1 reference

Jason A Goebel

1

1 reference

PubMed ID

18752765

19 August 2017

Adrian B Van Bakel

series ordinal

2

1 reference

19 August 2017

1 September 2008

1 reference

Current heart failure reports

19 August 2017

1 reference

19 August 2017

5

1 reference

19 August 2017

3

1 reference

19 August 2017

153-162

1 reference

https://scigraph.springernature.com/pub.10.1007/s11897-008-0024-y

19 August 2017

0 references

cites work

Loop diuretics: from the Na-K-2Cl transporter to clinical use.

1 reference

https://api.crossref.org/works/10.1007%2FS11897-008-0024-Y

Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-008-0024-Y

Why do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting-enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-008-0024-Y

The dose-response characteristics of the acute non-diuretic peripheral vascular effects of frusemide in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-008-0024-Y

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-008-0024-Y

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-008-0024-Y

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-008-0024-Y

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

21 January 2018

1 reference

12 December 2020

Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure

1 reference

12 December 2020

Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor.

1 reference

12 December 2020

Comparison of loop diuretics in patients with chronic renal insufficiency

1 reference

12 December 2020

Direct cardiac effects of vasopressin: role of V1- and V2-vasopressinergic receptors

1 reference

12 December 2020

Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure

1 reference

12 December 2020

Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion

1 reference

12 December 2020

Acute decompensated heart failure and the cardiorenal syndrome

1 reference

12 December 2020

Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction.

1 reference

12 December 2020

Chronic administration of aldosterone depresses baroreceptor reflex function in the dog

1 reference

12 December 2020

BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy

1 reference

12 December 2020

Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure

1 reference

12 December 2020

Diuretic therapy and resistance in congestive heart failure

1 reference

12 December 2020

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

1 reference

12 December 2020

Continuous infusion versus bolus injection of loop diuretics in congestive heart failure

1 reference

12 December 2020

The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance

1 reference

12 December 2020

The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction

1 reference

12 December 2020

Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators

1 reference

12 December 2020

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics

1 reference

12 December 2020

Adenosine and kidney function: potential implications in patients with heart failure

1 reference

12 December 2020

Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.

1 reference

12 December 2020

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

1 reference

12 December 2020

Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema

1 reference

12 December 2020

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

1 reference

12 December 2020

The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure

1 reference

12 December 2020

Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Adaptation of distal tubule and collecting duct to increased Na delivery. II. Na+ and K+ transport

1 reference

12 December 2020

Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction

1 reference

12 December 2020

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

1 reference

12 December 2020

Adaptation of distal tubule and collecting duct to increased sodium delivery. I. Ultrastructure

1 reference

12 December 2020

Cardiorenal interactions: insights from the ESCAPE trial

1 reference

12 December 2020

The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)

1 reference

12 December 2020

Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure

1 reference

12 December 2020

Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD)

1 reference

12 December 2020

The physiological effects of elevated intra-abdominal pressure following aneurysm repair

1 reference

12 December 2020

Practical applications of intravenous diuretic therapy in decompensated heart failure

1 reference

12 December 2020

The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment

1 reference

12 December 2020

1 reference

12 December 2020

Instantaneous restoration of regional organ blood flow after severe hemorrhage: effect of small-volume resuscitation with hypertonic-hyperoncotic solutions.

1 reference

12 December 2020

Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure

1 reference

12 December 2020

Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure

1 reference

12 December 2020

Diuretic resistance predicts mortality in patients with advanced heart failure

1 reference

12 December 2020

Combined therapy with thiazide-type and loop diuretic agents for resistant sodium retention

1 reference

12 December 2020

Remodeling of the rat right and left ventricles in experimental hypertension

1 reference

12 December 2020

Comparison of hemodynamic and biochemical effects of furosemide by continuous infusion and intermittent bolus in critically ill patients

1 reference

12 December 2020

Relationship between heart failure treatment and development of worsening renal function among hospitalized patients

1 reference

12 December 2020

Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure

1 reference

12 December 2020

Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure.

1 reference

12 December 2020

Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials

1 reference

12 December 2020

10.1007/S11897-008-0024-Y

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18752765